Dr Nardone’s research focuses on pharmacovigilance and previously undetected and/or undefined drug adverse events and co-morbidities utilizing real world data related to dermatology. As a senior researcher with RADAR (Research on Adverse Drug events And Report) and through the detection of safety signals from “big data “, Dr Nardone effectively conducts data mining that utilizes various data sources, including the FDA and other national database as well as electronic health records, to report new associations that reflect serious adverse events and comorbidities relatable to dermatology practice. Another important dimension to her research focus is the use of state of the art non-invasive instrumentation to augment the diagnostic capabilities of the dermatologist, including, among others, dermoscopy, capillaroscopy and confocal reflectance microscopy technology.